ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

News from the ECOG-ACRIN Cancer Research Group
September 17, 2024
Green tea catechin pills
September 17, 2024
Categories
  • Active Clinical Trials

Trial Spotlight: Nagi Kumar on the EA8184 Study for Men with Low-Grade Prostate Cancer on Active Surveillance

A recent amendment expands eligibility for this phase 2 trial evaluating the use of green tea catechin pills to help prevent progression
Do you like it?
0 Read more
September 17, 2024
Research definition
September 17, 2024
Categories
  • Trial Results

Trial Results: ECOG-ACRIN Research Round-Up

Summaries of recently published ECOG-ACRIN research results
Do you like it?
0 Read more
September 17, 2024
News in Brief
September 17, 2024
Categories
  • News in Brief

News in Brief, September 2024

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
Do you like it?
0 Read more
August 14, 2024
Dr. O'Dwyer and Dr. Schnall
August 14, 2024
Categories
  • From the Co-Chairs

From the Co-Chairs, August 2024

Thoughts on the evolving clinical cancer research environment—and practice-changing results in acute lymphoblastic leukemia
Do you like it?
0 Read more
August 22, 2024
August 22, 2024
Categories
  • Active Clinical Trials

Now Enrolling: EA3231 for Patients With BRAF-Mutated Differentiated Thyroid Cancer

This phase 3 study is comparing BRAF-targeted therapy with dabrafenib-trametinib to TKI therapy with cabozantinib in patients with disease progression following standard treatments
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org

Tags

Acute lymphoblastic leukemia (ALL) Advanced practice providers Advocacy ASCO Breast cancer Cancer care delivery research Cancer screening Cancer surveillance Chemotherapy Clinical trials Colorectal cancer ComboMATCH Comis Symposium Communication COVID-19 Diversity GI cancer Group Meeting Head and neck cancer Head and neck squamous cell carcinoma Health equity Immunotherapy In memory Kidney cancer Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Myeloma NCI NCI-MATCH NCORP Non-small cell lung cancer Pancreatic cancer Precision medicine Prostate cancer Real-world data Research results Sarcoma Social determinants of health Survivorship Targeted therapy TMIST
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2024 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc